About Auro Laboratories
Auro Laboratories is a company based in Mumbai (India) founded in 1992. The company has 49 employees as of October 31, 2024. Auro Laboratories operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Mumbai, India
- Employees 49 as on 31 Oct, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Auro Laboratories Limited
-
Annual Revenue
$6.66 M (USD)2as on Mar 31, 2024
-
Net Profit
$941.33 K (USD)219as on Mar 31, 2024
-
EBITDA
$1.47 M (USD)128as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
49
as on Oct 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Auro Laboratories
Auro Laboratories is a publicly listed company on the BSE with ticker symbol AUROLAB in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Auro Laboratories
Detailed funding history for Auro Laboratories
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Auro Laboratories
Investment portfolio details for Auro Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Auro Laboratories
Detailed financials for Auro Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Auro Laboratories Comparisons
Peer comparison for Auro Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Auro Laboratories
Auro Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Auro Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Auro Laboratories
Complete news archive for Auro Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Auro Laboratories
Auro Laboratories was founded in 1992.
Auro Laboratories is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Sharat Deorah is the current CEO of Auro Laboratories.
As of Oct 31, 2024, the latest employee count at Auro Laboratories is 49.
Annual revenue of Auro Laboratories is $6.66M as on Mar 31, 2024.
Active pharmaceutical ingredients, intermediates, and generic formulations are produced by Auro Laboratories, with a focus on anti-diabetic drugs. Custom manufacturing of APIs and intermediates is undertaken on a contract basis. Founded in 1992 and based in Mumbai, India, products are exported to South East Asia, the Middle East, and several European countries, adhering to European and US pharmacopoeia standards.
Auro Laboratories's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Yes, Auro Laboratories is publicly traded on BSE under the ticker symbol AUROLAB.
The ticker symbol of Auro Laboratories is AUROLAB on BSE.